Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Food and Drug Administration (FDA) for safety or effectiveness
Physiology, Pineal Gland
Transparent cash-pay pricing and broad in-network coverage including Anthem, Aetna, Cigna, Humana, United Healthcare, Medicare, and most Medicaid plans
Transgenic female mice treated with intranasal GHK-Cu had higher alternation percentages in the Y maze, indicating improved cognitive performance, beginning as early as the second month of treatment (Week 8), and continuing through the third month (Week 12) when the study ended, compared to transgenic mice treated with intranasal saline (Figure 1A)
US$ 24.64
US$ 20.27
US$ 27.44
US$ 23.82
